Franklin Genomic Advancements ETF (HELX) Holdings $28.55 -1.41 (-4.71%) (As of 11/15/2024 ET) Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatings Top 50 HELX HoldingsRankCompanyCurrent PriceWeightShares Held1MEDPMedpace$310.63-7.2%5.91%1,9412VRTXVertex Pharmaceuticals$465.70-3.8%5.79%1,3073DHRDanaher$230.50-3.7%5.27%2,1804REGNRegeneron Pharmaceuticals$756.81-3.3%5.00%5645LLYEli Lilly and Company$746.20-4.9%4.97%6106TMOThermo Fisher Scientific$513.08-3.7%4.96%931 Get the Latest News and Ratings for HELX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. 7KRYSKrystal Biotech$170.74-3.7%4.25%2,7068NTRANatera$146.06-3.3%3.80%3,4959Samsung Biologics Co.,Ltd.N/A3.80%57010AZNAstraZeneca$63.23-2.8%2.68%3,86611Sartorius AktiengesellschaftN/A2.39%93412CTVACorteva$55.21-3.8%2.27%4,32813INSMInsmed$66.29-7.0%2.11%3,19614AAgilent Technologies$127.07-2.4%2.08%1,70415IONSIonis Pharmaceuticals$34.34-7.8%2.05%5,99016BRKRBruker$51.30-5.9%2.01%3,73517ALNYAlnylam Pharmaceuticals$235.56-8.7%1.99%75318CDNSCadence Design Systems$289.71-4.4%1.98%84719CRLCharles River Laboratories International$187.74-4.7%1.95%1,11120UTHRUnited Therapeutics$363.25-6.0%1.86%56021BNTXBioNTech$99.72-3.7%1.85%1,82122QGENQiagen$41.27-1.9%1.85%4,88723EXASExact Sciences$49.33-3.1%1.73%2,80724ICLRICON Public$189.64-5.2%1.66%63425RCKTRocket Pharmaceuticals$13.98-5.7%1.57%9,56726SRPTSarepta Therapeutics$104.54-4.2%1.56%1,41027RVTYRevvity$109.52-5.6%1.48%1,40228RAREUltragenyx Pharmaceutical$44.75-6.1%1.46%2,89629Lonza Group AGN/A1.24%21930TWSTTwist Bioscience$36.89-5.3%1.22%3,02731IQVIQVIA$192.68-5.1%1.13%54332VYGRVoyager Therapeutics$5.64-9.3%1.11%15,59133LHLaboratory Co. of America$235.21-1.2%0.97%50834BBIOBridgeBio Pharma$23.72-1.6%0.92%3,96335TECHBio-Techne$67.57-6.9%0.91%1,46036LGNDLigand Pharmaceuticals$111.71-3.2%0.88%93937AZTAAzenta$41.51-2.6%0.86%2,21638BEAMBeam Therapeutics$24.05-8.6%0.86%3,96539NBIXNeurocrine Biosciences$117.44-4.4%0.84%79640NTLAIntellia Therapeutics$13.97-7.6%0.83%4,448Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide41CDMOAvid Bioservices$12.14+1.8%0.80%8,91642MRNAModerna$36.85-7.3%0.79%1,62743Us DollarN/A0.68%76,11644CRSPCRISPR Therapeutics$47.25+0.9%0.65%1,52245RXRXRecursion Pharmaceuticals$6.18-10.7%0.57%9,78246RGENRepligen$124.73-12.4%0.54%43147BIOBio-Rad Laboratories$320.31-8.5%0.53%17548AVTRAvantor$20.74-1.9%0.50%2,26949FDMT4D Molecular Therapeutics$8.83+10.1%0.44%5,84850NGNENeurogene$34.52-12.0%0.41%878 Geographic ExposureUnited States87.3%Korea, Republic of4.6%Germany2.2%Switzerland1.8%Ireland1.2%Denmark0.3%Currency ExposureUSD91.6%KRW4.6%EUR2.2%CHF1.3%DKK0.3%Sector ExposureHealth Care81.9%Materials3.7%Technology3.5%Cash or Derivatives0.7%Consumer Discretionary0.5%Real Estate0.2%Industry ExposureBiotechnology43.5%Health Care Equipment & Supplies19.8%Health Care Providers & Services9.7%Life Sciences Tools & Services5.1%Diversified Consumer Services4.3%Chemicals3.7%Software2.6%Semiconductors & Semiconductor Equipment0.9%Cash or Derivatives0.7%Real Estate Management & Development0.2%SubIndustry ExposureBiotechnology44.0%Life Sciences Tools & Services26.6%Health Care Services9.7%Application Software2.6%Fertilizers & Agricultural Che2.4%Health Care Equipment2.1%Specialty Chemicals1.3%Semiconductors0.9%Cash or Derivatives0.7%REIT0.2% Related Companies and Tools Related Companies MOTO Portfolio Companies SPCX Portfolio Companies COPJ Portfolio Companies GCLN Portfolio Companies RBLD Portfolio Companies AQWA Portfolio Companies NIKL Portfolio Companies SIMS Portfolio Companies IVRA Portfolio Companies GFOF Portfolio Companies This page (BATS:HELX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.